<DOC>
	<DOCNO>NCT01857050</DOCNO>
	<brief_summary>Many drug interaction Warfarin well document literature , include interaction variety antibiotic . However , mamy case difficult predict interaction remain theoretical becomes clinically significant reflect individual patient . This study 's aim identify characterize related condition ( include comorbidities , laboratory test result parameter related patient ) might predictor drug interaction turn theoretical clinically significant .</brief_summary>
	<brief_title>Assessment International Normalized Ratio ( INR ) Prolongation Patients Treated Simultaneously With Warfarin Cephalosporins</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients age 18 Patients treated combination Warfarin Cephalosporins Patients hospitalize department internal medicine Patients treat Warfarin without Cefalosporins Patients Warfarin actually receive drug hospitalization Patients whose medical record accessible n't contain full data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>